Maternal and perinatal implications of the use of human recombinant erythropoietin

Abstract

Among the cases presented, no maternal and perinatal complications attributable to rHuEPO were registered. It is important that institutions report their experiences with the use of rHuEPO, given its restrictive indications and the limited experience of each institution.